This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Anna Ingrid Kristina Berggren: Innovator in Selective Inhibitors
Introduction
Anna Ingrid Kristina Berggren is a notable inventor based in Molndal, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors. Her work is recognized for its potential impact on medical treatments.
Latest Patents
Anna holds a patent for "JAK1 Selective Inhibitors," which showcases her innovative approach to targeting specific pathways in disease treatment. This patent is a testament to her expertise and dedication to advancing medical science. She has 1 patent to her name.
Career Highlights
Anna is currently employed at AstraZeneca UK Limited, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to work on cutting-edge research and development projects that aim to improve patient outcomes.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Karl Magnus Nilsson and Annika Birgitta Margareta Åstrand. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Anna Ingrid Kristina Berggren is a pioneering inventor whose work in selective inhibitors is shaping the future of pharmaceuticals. Her contributions to AstraZeneca and the field of medicine are commendable and reflect her commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile